flecainide

96 Effectiveness of outpatient screening for the proarrhythmic effects of flecainide
Nathan Denham, Mark Hall, Saagar Mahida, Simon Modi, Richard Snowdon, Dhiraj Gupta, Zoltan Borbas, Derick Todd, Vishal Luther, Johan Waktare

Heart Jun 2022, 108 (Suppl 1) A72-A73; DOI: 10.1136/heartjnl-2022-BCS.96
169 PITX2C deficiency augments the anti-arrhythmic properties of flecainide: results in a mouse model and validation in a human atrium simulation study
Fahima Syeda, Andrew P Holmes, Ting Y Yu, Samantha P Tull, Genna Riley, Florian Jousset, Jan Kucera, Stephan Rohr, Larissa Fabritz, Paulus Kirchhof

Heart Jun 2015, 101 (Suppl 4) A96; DOI: 10.1136/heartjnl-2015-308066.169
Randomised double blind trial of oral versus intravenous flecainide for the cardioversion of acute atrial fibrillation
N J Alp, J A Bell, M Shahi

Heart Jul 2000, 84 (1) 37-40; DOI: 10.1136/heart.84.1.37
Electrophysiological effects of flecainide and propafenone on atrial fibrillation cycle and relation with arrhythmia termination
M Biffi, G Boriani, G Bronzetti, A Capucci, A Branzi, B Magnani

Heart Aug 1999, 82 (2) 176-182; DOI: 10.1136/hrt.82.2.176

Main menu